Wednesday, 25 June 2025 19:05
ALZHEIMERS DRUG APPROVEDS FOR DISPENSING
KISUNLA (donanemab), a new Alzheimer's treatment, has been approved in Australia for early-stage patients with a specific genetic profile and confirmed amyloid plaque build-up. It’s the first treatment in 25 years to target the disease's cause by clearing brain plaques. Administered monthly, Kisunla aims to preserve independence longer. With 450,000 Australians in early stages potentially eligible, the drug’s PBS listing will be reviewed in July. Experts call it a breakthrough and urge support for early detection and access.
Published in
Default Set
Wednesday, 25 June 2025 19:04
RESEARCH SHOWS NURSES ARE UNPREPARED
NEW research from Charles Darwin University reveals Australian nurses are underprepared for disasters, despite responding to hundreds of events since 2019—roughly one every 10 days. Lead author Angela Sheedy says nurses, though highly skilled, often react rather than proactively manage crises like pandemics, terror attacks, or environmental contamination. With climate change and other modern risks increasing disaster frequency, Sheedy calls for mandatory all-hazards training in nursing education to strengthen resilience and improve community outcomes during emergencies
Published in
Default Set
Wednesday, 25 June 2025 19:03
GPs CAN NOW DIAGNOSE ADHD
THE NSW Government will allow trained GPs to diagnose and treat ADHD, making access to care faster and more affordable. Currently reliant on costly specialists, patients often face long waits. Under the reforms, GPs can provide ongoing prescriptions for stable cases, and selected GPs will diagnose and initiate treatment. NSW Health will fund training and support for up to 1000 GPs. Reforms begin with children in 2026, aiming to reduce developmental delays and improve outcomes. NSW follows similar moves in QLD and WA.
Published in
Default Set